journal article Nov 01, 2014

Transforming the Promise of Pluripotent Stem Cell-Derived Cardiomyocytes to a Therapy: Challenges and Solutions for Clinical Trials

Canadian Journal of Cardiology Vol. 30 No. 11 pp. 1335-1349 · Elsevier BV
View at Publisher Save 10.1016/j.cjca.2014.08.005
Topics

No keywords indexed for this article. Browse by subject →

References
113
[1]
Embryonic Stem Cell Lines Derived from Human Blastocysts

James A. Thomson, Joseph Itskovitz-Eldor, Sander S. Shapiro et al.

Science 1998 10.1126/science.282.5391.1145
[2]
Menasché "Stem cell therapy for chronic heart failure: lessons from a 15-year experience" C R Biol (2011) 10.1016/j.crvi.2011.03.006
[3]
Li "Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells" J Am Coll Cardiol (2012) 10.1016/j.jacc.2011.11.029
[4]
Hamdi "Long-term functional benefits of epicardial patches as cell carriers" Cell Transplant (2014) 10.3727/096368912x658836
[5]
Pagani "Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation" J Am Coll Cardiol (2003) 10.1016/s0735-1097(03)00081-0
[6]
Mirotsou "Paracrine mechanisms of stem cell reparative and regenerative actions in the heart" J Mol Cell Cardiol (2011) 10.1016/j.yjmcc.2010.08.005
[7]
Jeevanantham "Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis" Circulation (2012) 10.1161/circulationaha.111.086074
[8]
Roger "Heart disease and stroke statistics–2011 update: a report from the American Heart Association" Circulation (2011) 10.1161/cir.0b013e3182009701
[9]
Dickstein Eur Heart J (2008) 10.1093/eurheartj/ehn309
[10]
Stewart "Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004)" Circ Cardiovasc Qual Outcomes (2010) 10.1161/circoutcomes.110.957571
[11]
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure

Emma J. Birks, Patrick D. Tansley, James Hardy et al.

New England Journal of Medicine 2006 10.1056/nejmoa053063
[12]
Reffelmann "Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy" J Am Coll Cardiol (2009) 10.1016/j.jacc.2008.10.018
[13]
Assmus "Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction" Circ Heart Fail (2010) 10.1161/circheartfailure.108.843243
[14]
Traverse "Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial" JAMA (2012) 10.1001/jama.2012.28726
[16]
Bolli "Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial" Lancet (2011) 10.1016/s0140-6736(11)61590-0
[17]
Makkar "Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial" Lancet (2012) 10.1016/s0140-6736(12)60195-0
[18]
Williams "Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease" Circ Res (2011) 10.1161/circresaha.111.243147
[19]
Loffredo "Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair" Cell Stem Cell (2011) 10.1016/j.stem.2011.02.002
[20]
Garbern "Cardiac stem cell therapy and the promise of heart regeneration" Cell Stem Cell (2013) 10.1016/j.stem.2013.05.008
[21]
Mummery "Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview" Circ Res (2012) 10.1161/circresaha.110.227512
[22]
Burridge "Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming" Cell Stem Cell (2012) 10.1016/j.stem.2011.12.013
[23]
Yang "Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population" Nature (2008) 10.1038/nature06894
[24]
Elliott "NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes" Nat Methods (2011) 10.1038/nmeth.1740
[25]
Kattman "Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines" Cell Stem Cell (2011) 10.1016/j.stem.2010.12.008
[26]
Lian "Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions" Nat Protoc (2013) 10.1038/nprot.2012.150
[27]
Lian "Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling" Proc Natl Acad Sci U S A (2012) 10.1073/pnas.1200250109
[28]
Ren "Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells" J Mol Cell Cardiol (2011) 10.1016/j.yjmcc.2011.04.012
[29]
Bondue "Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification" Cell Stem Cell (2008) 10.1016/j.stem.2008.06.009
[30]
David "Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell" Cardiovasc Res (2011) 10.1093/cvr/cvr158
[31]
Costello "The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation" Nat Cell Biol (2011) 10.1038/ncb2304
[32]
David "MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling" Nat Cell Biol (2008) 10.1038/ncb1696
[33]
Osafune "Marked differences in differentiation propensity among human embryonic stem cell lines" Nat Biotechnol (2008) 10.1038/nbt1383
[34]
Burridge "Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability" Stem Cells (2007) 10.1634/stemcells.2006-0598
[35]
Stefanovic "Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate" J Cell Biol (2009) 10.1083/jcb.200901040
[36]
Gafni "Derivation of novel human ground state naive pluripotent stem cells" Nature (2013) 10.1038/nature12745
[37]
Zhang "Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method" Circ Res (2012) 10.1161/circresaha.112.273144
[38]
Blin "A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates" J Clin Invest (2010) 10.1172/jci40120
[39]
Hentze "Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies" Stem Cell Res (2009) 10.1016/j.scr.2009.02.002
[40]
He "Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization" Circ Res (2003) 10.1161/01.res.0000080317.92718.99
[41]
Ma "High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents" Am J Physiol Heart Circ Physiol (2011) 10.1152/ajpheart.00694.2011
[42]
Chen "Electrophysiological challenges of cell-based myocardial repair" Circulation (2009) 10.1161/circulationaha.107.751412
[43]
Gepstein "In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies" Stem Cells (2010) 10.1002/stem.545
[44]
Evseenko "Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells" Proc Natl Acad Sci U S A (2010) 10.1073/pnas.1002077107
[45]
Bizy "Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes" Stem Cell Res (2013) 10.1016/j.scr.2013.09.003
[46]
Uosaki "Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression" PLoS One (2011) 10.1371/journal.pone.0023657
[47]
Dubois "SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells" Nat Biotechnol (2011) 10.1038/nbt.2005
[48]
Tohyama "Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes" Cell Stem Cell (2013) 10.1016/j.stem.2012.09.013
[49]
Hattori "Nongenetic method for purifying stem cell-derived cardiomyocytes" Nat Methods (2010) 10.1038/nmeth.1403
[50]
Huber "Identification and selection of cardiomyocytes during human embryonic stem cell differentiation" FASEB J (2007) 10.1096/fj.05-5711com

Showing 50 of 113 references

Metrics
20
Citations
113
References
Details
Published
Nov 01, 2014
Vol/Issue
30(11)
Pages
1335-1349
License
View
Cite This Article
Andrew B.J. Prowse, Nicholas E. Timmins, Terrence M. Yau, et al. (2014). Transforming the Promise of Pluripotent Stem Cell-Derived Cardiomyocytes to a Therapy: Challenges and Solutions for Clinical Trials. Canadian Journal of Cardiology, 30(11), 1335-1349. https://doi.org/10.1016/j.cjca.2014.08.005